Top-News

ConforMIS News

Aktie
WKN:  A3DZF8 ISIN:  US20717E2000 US-Symbol:  CFMS
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
7,52 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 14.11.2022

ConforMIS News

09.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, EQRX, CFMS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, EQRX, CFMS PR Newswire
01.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, TALS, QUOT, CFMS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, TALS, QUOT, CFMS PR Newswire
18.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMS PR Newswire
11.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, QUOT, TALS, CFMS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, QUOT, TALS, CFMS PR Newswire
29.06.23 - PR Newswire
IMPORTANT ALERT: Halper Sadeh LLC Investigates KLR, QUOT, CFMS
IMPORTANT ALERT: Halper Sadeh LLC Investigates KLR, QUOT, CFMS PR Newswire
23.06.23 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d PR Newswire
23.06.23 - PR Newswire
IMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA
IMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA PR Newswire
23.06.23 - PR Newswire
Thinking about buying stock in Xpeng, Nio, Applied Optoelectronics Inc, ConforMIS, or Applied DNA Sciences?
Thinking about buying stock in Xpeng, Nio, Applied Optoelectronics Inc, ConforMIS, or Applied DNA Sciences? PR Newswire
23.07.21 - PR Newswire
Thinking about buying stock in Veoneer, Abeona Therapeutics, ConforMIS, Neurobo Pharmaceuticals, or Acutus Medical?
Thinking about buying stock in Veoneer, Abeona Therapeutics, ConforMIS, Neurobo Pharmaceuticals, or Acutus Medical? PR Newswire
20.07.21 - PR Newswire
Thinking about buying stock in Immunome, Aldeyra Therapeutics, New Oriental Education, ConforMIS, or Cytokinetics?
Thinking about buying stock in Immunome, Aldeyra Therapeutics, New Oriental Education, ConforMIS, or Cytokinetics? PR Newswire
19.07.21 - PR Newswire
Thinking about buying stock in Cytokinetics, Property Solutions Acquisition, Imara, ConforMIS, or Sesen Bio?
Thinking about buying stock in Cytokinetics, Property Solutions Acquisition, Imara, ConforMIS, or Sesen Bio? PR Newswire
15.07.21 - PR Newswire
Thinking about buying stock in Cinedigm, Arlo Technologies, Velodyne Lidar, Jaguar Health, or ConforMIS?
Thinking about buying stock in Cinedigm, Arlo Technologies, Velodyne Lidar, Jaguar Health, or ConforMIS? PR Newswire
24.06.21 - GlobeNewswire
Conformis, Inc. gibt exklusive Vertriebsvereinbarung in China bekannt
Neue Vereinbarung erweitert globale Reichweite von Conformis und bringt patientenindividuelle Kniegelenkimplantatsysteme auf den größten Markt der Region Asien-​Pazifik
23.06.21 - PR Newswire
Thinking about buying stock in ConforMIS, Citius Pharmaceuticals, Clover Health, Capricor Therapeutics, or Dare Bioscience?
Thinking about buying stock in ConforMIS, Citius Pharmaceuticals, Clover Health, Capricor Therapeutics, or Dare Bioscience? PR Newswire
23.06.21 - GlobeNewswire
Conformis, Inc. Announces Exclusive Distribution Agreement in China
New Agreement expands Conformis’ global reach and brings patient-​specific knee replacement systems to the largest market in the Asia-​Pacific region
10.05.21 - PR Newswire
Thinking about buying stock in ConforMIS, Party City Holdco, Vyne Therapeutics, Mustang Bio, or Inovio Pharmaceuticals?
Thinking about buying stock in ConforMIS, Party City Holdco, Vyne Therapeutics, Mustang Bio, or Inovio Pharmaceuticals? PR Newswire
25.03.21 - GlobeNewswire
Klinische Studie: Patientenspezifischer Kniegelenkersatz mit Conformis-Technologie ist kostengünstiger als führende gebrauchsfertige Implantate
Eine unabhängige, retrospektive Analyse chirurgischer Daten aus den Jahren 2016-2019 durch Forscher der University of Washington zeigt, dass Conformis iTotal®-...
17.03.21 - GlobeNewswire
Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants
Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal® knee replacement implants enable ...
02.03.21 - PR Newswire
Thinking about buying stock in ConforMIS, Inuvo, Rocket Companies, Fortress Biotech, or Perion Network?
Thinking about buying stock in ConforMIS, Inuvo, Rocket Companies, Fortress Biotech, or Perion Network? PR Newswire
22.02.21 - PR Newswire
Thinking about buying stock in Celsion Corp, Can Fite Biopharma, ConforMIS Inc, Citius Pharmaceuticals, or Vuzix Corp?
Thinking about buying stock in Celsion Corp, Can Fite Biopharma, ConforMIS Inc, Citius Pharmaceuticals, or Vuzix Corp? PR Newswire

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »